[1]吴水清,黄建成,李达周,等.OLGA及OLGIM分期系统对1790例慢性萎缩性胃炎患者胃癌风险的评估价值[J].陕西医学杂志,2021,50(6):756-758.[doi:DOI:10.3969/j.issn.1000-7377.2021.06.029]
　WU Shuiqing,HUANG Jiancheng,LI Dazhou,et al.Value of OLGA and OLGIM staging system in evaluating the risk of gastric cancer in 1790 patients with chronic atrophic gastritis[J].,2021,50(6):756-758.[doi:DOI:10.3969/j.issn.1000-7377.2021.06.029]
点击复制

OLGA及OLGIM分期系统对1790例慢性萎缩性胃炎患者胃癌风险的评估价值
分享到：

《陕西医学杂志》[ISSN:1000-7377/CN:61-1281/TN]

卷:
50
期数:
2021年6期
页码:
756-758
栏目:
临床病理
出版日期:
2021-06-05

文章信息/Info

Title:
Value of OLGA and OLGIM staging system in evaluating the risk of gastric cancer in 1790 patients with chronic atrophic gastritis
作者:
吴水清1; 黄建成1; 李达周2; 王 雯2; 陆 晶1
(1.福建医科大学附属闽东医院消化内科,福建 宁德 355000; 2.解放军联勤保障部队第九〇〇医院消化内科,福建 福州 350000)
Author(s):
WU Shuiqing; HUANG Jiancheng; LI Dazhou; WANG Wen; LU Jing
(Department of Gastroenterology,Mindong Hospital,Fujian Medical University,Ningde 355000,China)
关键词:
可操作的与胃癌风险联系的萎缩评估;  可操作的与胃癌风险联系的肠化生评估;  慢性萎缩性胃炎;  上皮内瘤变;  幽门螺杆菌
Keywords:
OLGA;  OLGIM;  Chronic atrophic gastritis;  Intraepithelial neoplasia;  Helicobacter pylori
分类号:
R 573.32
DOI:
DOI:10.3969/j.issn.1000-7377.2021.06.029
文献标志码:
A
摘要:
目的:探讨可操作的与胃癌风险联系的萎缩评估(OLGA)和可操作的与胃癌风险联系的肠化生评估(OLGIM)系统对慢性萎缩性胃炎(CAG)癌变风险的评估价值。方法:1790例CAG患者为研究对象,记录基本资料以及胃镜、病理、幽门螺杆菌(HP)检查结果,分析OLGA/OLGIM分期与胃黏膜病变的相关性,比较不同OLGA/OLGIM分期患者HP感染情况。结果:1790例CAG中,病理表现为萎缩908例(50.73%),肠化生1384例(77.32%),上皮内瘤变(含癌变)185例(10.34%); OLGA分期中,0期、Ⅰ期、Ⅱ期、Ⅲ期、Ⅳ期分别有882例、687例、170例、44例和7例; OLGIM分期中,0期、Ⅰ期、Ⅱ期、Ⅲ期、Ⅳ期分别有406例、1092例、221例、53例和18例。OLGA及OLGIM分期与胃黏膜病变均呈正相关(rs=0.096、0.138,均P<0.05)。OLGA及OLGIM各分期HP感染率比较总体差异均具有统计学意义(均P<0.05)。结论:OLGA及OLGIM分期系统对胃癌风险评估具有一定临床价值。
Abstract:
Objective:To explore the value of the OLGA and OLGIM staging system in evaluating the risk of chronic atrophic gastritis(CAG).Methods:1790 CAG patients were collected as the research objects.Their basic data and the results of gastroscopy,pathology and HP examination were recorded.The correlation between OLGA/OLGIM staging and gastric mucosal lesions was analyzed.HP infection in patients with different OLGA/OLGIM staging was compared.Results:Among 1790 cases of CAG,the pathological manifestations were 908 cases of atrophy(50.73%),1384 cases(77.32%)of intestinal metaplasia,and 185 cases(10.34%)of intraepithelial neoplasia(including carcinogenesis); in OLGA staging,there were 882 cases in stage 0,687 cases in stage Ⅰ,170 cases in stage Ⅱ,44 cases in stage Ⅲ,and 7 cases in stage Ⅳ; in OLGIM staging,there were 406 cases in stage 0,1092 cases in stageⅠ,221 cases in stageⅡ,53 cases in stage Ⅲ,and 18 cases in stage Ⅳ.OLGA and OLGIM staging were positively correlated with gastric mucosal lesions(rs=0.096,0.138,all P<0.05).The overall difference in HP infection rates between OLGA and OLGIM staging were statistically significant(all P<0.05).Conclusion:OLGA and OLGIM staging system has certain clinical value for gastric cancer risk assessment.

参考文献/References:

[1] 王爱红,黄兰燕,米志宽.中药抑制胃癌肿瘤细胞增殖研究进展[J].陕西中医,2018,39(3):403-405.
[2] Ferlay J,Soerjomataram I,Dikshit R,et al.Cancer incidence and mortality worldwide:Sources,methods and major patterns in GLOBOCAN 2012[J].Int J Cancer,2015,136(5):359-386.
[3] 左婷婷,郑荣寿,曾红梅,等.中国胃癌流行病学现状[J].中国肿瘤临床,2017,44(1):52-58.
[4] Dixon MF,Genta RM,Yardley JH,et al.Classification and grading of gastritis.The updated sydney system.International workshop on the histopathology of gastritis,Houston 1994[J].Am J Surg Pathol,1996,20(10):1161-1181.
[5] Rugge M,Genta RM.Staging and grading of chronic gastritis[J].Hum Pathol,2005,36(3):228-233.
[6] Sipponen HP,Price AR.The sydlley system for classification of gastritis 20 years ago[J].J Gastroenterol Hepat,2011,26(1):31-34.
[7] Capetle LG,Vries AC,Haringsma J,et al.The staging of gastritis with the OLGA system by using intestinal metaplasia as an accurate alternative for atrophic gastritis[J].Gastrointest Endosc,2010,71(7):1150-1158.
[8] 房静远,杜奕奇,刘文忠,等.中国慢性胃炎共识意见(2017年,上海)[J].胃肠病学,2017,22(11):670-687.
[9] Du Y,Bai Y,Xie P,et al.Chronic gastritis in China:A national multi-center survey[J].BMC Gastroenterol,2014,14(1):21.
[10] 张贺军,金 珠,崔荣丽,等.OLGA分期、分级评估系统在胃镜活检组织病理学评价中的应用[J].中华消化内镜杂志,2014,31(3):121-125.
[11] 杜 亮,吴学勇,吴 伟.慢性萎缩性胃炎与胃镜、胃黏膜病理及幽门螺旋杆菌感染的相关性研究[J].陕西医学杂志,2017,46(12):1676-1677.
[12] Correa P,Fontham ET,Bravo JC,et al.Chemoprevention of gastric dysplasia:Randomized trial of antioxidant supplements and anti-helicobaterpylori therapy[J].J Natl Cancer Inst,2000,92:1881-1888.
[13] 吴水清,李达周,龚清全,等.福建宁德地区慢性萎缩性胃炎与幽门螺旋杆菌感染情况调查研究[J].陕西医学杂志,2020,49(6):763-765,769.
[14] 吴水清.胃癌低发区福建宁德慢性萎缩性胃炎与幽门螺旋杆菌感染情况[D].福州:福建医科大学,2019.
[15] Liu WZ,Xie Y,Cheng H,et al.Fourth Chinese national consensus report on the management of helicobacter pylori infection[J].J Dig Dis,2013,14(5):211-221.
[16] 余 明,王 博,张亚飞,等.癌前病变及胃癌与幽门螺杆菌感染的关系探讨[J].陕西医学杂志,2018,47(11):1424-1426.
[17] 高 鹏,王玉平,周永宁.胃癌与幽门螺杆菌相关性研究进展[J].胃肠病学和肝病学杂志,2016,25(1):1-4.
[18] 宋洁莹,李海燕,朱凌音,等.放大内镜结合窄带成像技术指导活检对诊断早期胃癌的重要性[J].中华消化内镜杂志,2014,31(8):455-458.
[19] 王芳军,汪 娟,赵 可,等.放大结合窄带成像在上消化道内镜检查中指导靶向活检的价值[J].中华消化内镜杂志,2014,31(7):393-397.
[20] Pimentel-Nunes P,Libanio D,Lage J,et al.A muhicenter prospective study of the real-time use of narrow-band imaging in the diagnosis of premalignant gastric conditions and lesions [J].Endoscopy,2016,48(8):723-730.

更新日期/Last Update: 2021-06-07